Biolase, Inc (BIOL) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Biolase, Inc

CIK: 811240 Ticker: BIOL

View differences made from one to another to evaluate Biolase, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biolase, Inc.


Assess how Biolase, Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biolase, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: BIOL
CIK: 811240
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-262404
Submitted to the SEC: Fri Oct 04 2019 11:19:59 AM EST
Accepted by the SEC: Fri Oct 04 2019
Period: Monday, September 30, 2019
Industry: Dental Equipment And Supplies
  1. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: